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1. INTRODUCTION 
There is widespread acknowledgment of the 
importance of non-directive counselling in 
achieving informed acceptance and informed 
decline of prenatal testing for fetal abnormalities 
(Royal College of Physicians, 1989). We do not, 
however, know the extent to which this is achie- 
ved. Few studies have documented what, and 
how, information is provided to women eligible 
for such tests. 
The way in which information is presented 
may influence subsequent decision (McNeil et 
al, 1982). In an analogous study of prenatal tes- 
ting, subjects were more likely to choose to have 
amniocentesis if the likelihood of having an 
affected child was framed negatively (i.e a 20% 
likelihood of having an affected child) than if the 
likelihood was framed positively (i.e an 80% li- 
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kelihood that there is no abnormality; Marteau, 
1989a). In a retrospective study of women refer- 
red for amniocentesis following an abnormal 
result on a routine screening test, maternal serum 
alpha-fetoprotein, women reported that they had 
been encouraged to undergo the test by their 
obstetricians (Farrant, 1985). Furthermore, Far- 
rant argued that they were not provided with suf- 
ficient information with which to make an 
informed choice about whether to undergo 
amniocentesis. For example, of 112 women in- 
terviewed after amniocentesis, 24% were unawa- 
re that the procedure carried a risk of miscar- 
riage. In another retrospective study of women’s 
decisions regarding routine amniocentesis becau- 
se of maternal age, the majority stated that their 
decisions were uninfluenced by the doctors and 
genetic counsellors they had seen as part of 
their routine care (Dixson et al., 198 1). 
It is difficult, however, to infer how amnio- 
centesis was actually presented and the relative 
contribution that test presentation might have 
had upon test uptake in these studies, given that 
they used retrospective designs and relied exclu- 
sively upon self-reports of the women concer- 
ned. Thus far there have been no observational 
studies of how amniocentesis is presented by 
doctors to eligible women. The aim of the cur- 
rent study is therefore to describe how obstetri- 
cians present amniocentesis to women eligible 
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because of their age and hence increased like- 
lihood of having a child with Down’s syndrome. 
centesis was coded, using a coding frame based 
on the categories shown in Table 1. 
2. METHODS 
2.1. Sample 
The sample comprised routine consultation:; 
between 25 women and 17 doctors. They all 
took place over a 3-month period in 1989 in one 
London teaching hospital. The women were 
aged 36 years or over at the expected date of 
delivery (mean age = 39.5, range 36-47), and 
were less than 16 weeks pregnant at the time of 
their first consultations with a doctor in the 
antenatal clinic. They had all seen a midwife for 
a booking-in consultation. Amniocentesis i s  
sometimes discussed during these consultations, 
but formal presentation of this test at the study 
hospital was seen as the province of obstetri- 
cians. None had undergone amniocentesis in :I 
previous pregnancy. Over a period of 3 months,, 
women eligible for amniocentesis solely became 
of maternal age, attending routine clinics, werc 
invited to participate in the study. None refused. 
The doctors in the study ranged in grade from 
senior house oficer to consultant. 
2.2. Measures 
The information provided during the consul- 
tation was coded under one of three categories: 
the conditions for which screening was being 
offered, including their nature, and likelihood alf 
occurrence; the procedure of amniocentesis, in- 
cluding the likelihood of miscarriage; and the 
likely action following a positive result, inc1u.- 
ding discussion of termination. Obstetricians,’ 
expressed attitudes towards the use of amniocenl- 
tesis were also coded. 
2.3. Procedure 
Following agreement to participate from both 
doctors and women, a tape-recorder was placed 
in the consulting room, switched on by a re- 
searcher, who then left the room. After the con.- 
sultation, the recorder was switched off. Tapes 
were transcribed and information about amnis- 
3. RESULTS 
Of the 25 women tape-recorded,23 subse- 
quently underwent amniocentesis. The test was 
discussed in all 25 consultations. The informa- 
tion provided most frequently concerned the 
probability of having a child with Down’s 
syndrome (21 occasions) and the probability of 
the procedure resulting in miscarriage (21 occa- 
sions). The probability of each of these events 
was contrasted on 14 occasions. Termination 
was mentioned in a minority of consultations 
(Table 1). 
The test was first mentioned in the consul- 
tation by the doctor on 18 occasions, and by the 
woman on seven. The primary condition for 
which screening was being offered, Down’s 
syndrome, was mentioned in 22 consultations, 
but never described. On eight occasions it was 
mentioned that other chromosome anomalies 
aside from Down’s syndrome were looked for. 
On five occasions, doctors mentioned that 
amniocentesis did not screen for all possible 
abnormalities. None of these conditions were 
ever described, e.g (107): 
Dr: ... it doesn’t necessarily guarantee you a 
normal baby but it does exclude some of the 
more common abnormalities which are associa- 
ted with us ladies as we get a bit older and we 
have our babies. 
On four occasions, women were led to believe 
that the test was more general than it actually is, 
e.g. (104): 
W And that can actually tell exactly how the 
baby is? 
Dr: Yes, it tells by its chromosomes so it tells 
you if its a perfectly normal boy or girl. They 
don’t tell you whether its a boy or a girl, they 
just tell you it’s a normal baby and then keep the 
sex a surprise. 
3.1. Probability ofDown 5 syndrome 
The probability of Down’s syndrome was re- 
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TABLE 1 
Information presented about amniocentesis during 25 routine consultations 
- 
1. 
2. 
3. 
4. 
Condition test screens for 
Down’s syndrome 
Other chromosome anomalies 
Spina bifida 
Description of conditioms 
Down’s syndrome 
Other chromosome anomalies 
Spina bifida 
Presentation of likelihood 
Down’s syndrome: 
Numbers 
Verbal description of likelihood 
Numerical and verbal descriptor 
Other chromosome anomalies 
Spina bifida 
Amniocentesis 
Likelihood of miscarriage 
Numbers 
Verbal descriptors of likelihood 
Numbers and verbal description 
Comparison of likelihood of Down‘s syndrome with those of fetal loss following amnio- 
centesis 
Meaning of results 
Implications of negative result does not mean baby is free of all congenital problems 
Implications of positive result 
Possible action, including termination 
Obstetricians’ attitudes towards amniocentesis 
Attitude made explicit 
Expressed before woman’s choice evident 
Expressed after woman’s choice evident 
22 
8 
6 
0 
0 
0 
21 
9 
6 
6 
0 
0 
21 
8 
3 
10 
14 
3 
9 
15 
10 
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presented numerically on nine occasions, e.g. 
Dr: The risk of you getting a Down’s baby is 
e.g (103) 
Dr: ... now by the time you are 40 the risk is 1 
in 100 ... when you are 41 the risk has gone up to 
1 in 88 ... 
On six occasions the risk was presented non- 
Dr: ... your risk starts to increase after the age 
(1 02): 
1 in 157 
numerically, e.g (024): 
of 37 years. Each year it gets higher. So I think 
if you’re 40 now its a reasonable thing to do. 
e.g (008): 
syndrome goes up as the years go by. 
On six occasions the probability was presen- 
ted numerically and then qualified verbally. e.g. 
Dr: Your chances for a baby with Down’s 
(104) 
Dr: Right, then the risk of you having a 
Down’s baby is 1 in 120, approximately. 119 
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times out of 120 you’ll have a normal baby, S ~ O  
it’s quite high really. 
e.g (109): 
Dr: Your risk of having a Down’s baby at 39 
is approximately 1 in 160 ... is a possibility, a 1 
in 160 possibility ... and it’s too high for you to 
take. 
3.2. Probability of miscarriage following am- 
niocentesis 
The probability of miscarriage following 
amniocentesis was presented in 2 1 consultation:;. 
On the majority of occasions these were presen- 
ted using numbers, sometimes in conjunction 
with qualifying adjectives. Most often the likeli- 
hood of a miscarriage was presented in conjun- 
ction with the likelihood of having a baby with 
Down’s syndrome (14/21), e.g (019): 
Dr: And the risk of a miscarriage is probably 
about 1 in 150. So the risk of a miscarriage is 
less than the risk of having a Down’s. So you’re 
more likely to have a Down’s than have a 
miscarriage after amniocentesis. 
e.g. (048): 
Dr: ... Yes, I think that really the risks of .it 
(Down’s syndrome) outweigh the risks of 
amniocentesis. 
3.3. Perceptions of risk 
The qualitative descriptions attached to nume- 
rical probabilities varied across doctors and with 
the nature of the event being described. Folr 
example, while one doctor described the proba.- 
bility of 1 in 120 for a child with Down’s syn- 
drome as quite high (1 04), another described the 
probability of 1 in 80 or 90 as being in the WO’- 
man’s favour (1 05). 
All doctors referred to probabilities as risks. 
The probability of miscarriage tended to be 
described as low, while similar probabilities of 
having an abnormal baby tended to be describe’d 
as high. A miscarriage rate of 1 in 100 was va- 
riously described as small (071; 008; 046) ver,y 
small (046), and very rare (017). By contrast:, 
risks of 1 in 120 and 1 in 160 (104;109) for a 
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baby with Down’s syndrome were described as 
high. 
3.4. Misinformation 
The probabilities given for both amniocentesis 
and Down’s syndrome varied, and hence, were 
sometimes inaccurate. For example, the probabi- 
lities presented for a miscarriage following am- 
niocentesis varied from ((higher than 1 in 100)) 
(107) to ((1 in 300 or 400 (008))) (true estimate = 
1 : 100; Tabor et al., 1986). The probabilities pre- 
sented for a baby having Down’s syndrome 
varied. One 40 year old woman was told that it 
was 1 in 157 (102), another 40 year old that it 
was 1 in 180 (103), yet another that it was as 
high as 1 in 50 (1 0 1) (true estimate 1 : 112, Har- 
per, 1991) 
3.4. Termination 
Termination of pregnancy following diagnosis 
of a fetal abnormality was mentioned on nine 
occasions. Sometimes it was mentioned by the 
obstetrician when making explicit the terms 
under which amniocentesis would be conducted, 
e.g. (055): 
Dr: I mean, obviously if you have the test 
done, the understanding is on your side as well 
that you will act on the results if they are found 
to be abnormal. 
e.g.(024) 
Dr: Do you understand that if you don’t want 
a termination there is no reason going through 
with it? 
Not all obstetricians held this view about the 
need for a woman to state her decision regarding 
termination if the result showed an abnormality 
prior to amniocentesis, e.g. (103): 
Dr: ... There is not much point in having the 
test (amniocentesis) if you don’t (want a termi- 
nation), although people don’t know how they 
are going to react if they are told that sort of 
thing (that the baby has an abnormality). 
Women’s attitudes towards termination for a 
fetal abnormality were never elicited directly, 
although they were sometimes given by women: 
e.g (101) 
W: I don’t want it (amniocentesis). The thing 
is, if anything is wrong, I could never justify an 
abortion. 
3 . 5 .  Attitudes towards abnormality 
These were discussed, elicited or mentioned 
by doctors on just one occasion, when a woman 
who declined amniocentesis stated that the birth 
of a child with Down’s syndrome would not be 
the end of the world (see 002 below) 
3.6. Obstetrician 5. attitudes towards amnio- 
centesis 
In 15 of the consultations the attitudes of the 
obstetrician towards the use of amniocentesis for 
women at risk of having a baby with Down’s 
syndrome because of raised age, was evident. 
On ten occasions the attitude was expressed 
before the woman’s choice was evident; on five 
occasions it was expressed after she had stated a 
choice. On nine occasions when attitudes were 
expressed to women who had made their choices 
explicit, the obstetricians’ attitudes were positive 
towards the use of amniocentesis, e.g. (061), to 
a woman aged 47: 
Dr: ... and certainly obviously at your age we 
would strongly advise the amniocentesis test 
whereby we can test the chromosome develop- 
ment in the baby and exclude Down’s syndrome. 
Dr: If you were my wife I would advise 
amniocentesis. 
A less positive, more neutral attitude towards 
amniocentesis was evident on just one occasion, 
for a woman pregnant with twins through IVF, 
(1 05): 
Dr: ... at 41 obviously the risk of having such 
a problem (Down’s syndrome) is probably about 
1 in 80 or 90 ... I mean the odds are very much in 
your favour.. . 
On three of the five occasions when attitudes 
were expressed after women had expressed a 
choice, these attitudes echoed women’s choices, 
which were to undergo the procedure, e.g. (046): 
Dr: ... I would do the same thing in your 
position 
e.g (008): 
Dr: ... I think you’re very wise. 
On the other two occasions when obstetricians 
expressed their attitudes towards the use of am- 
niocentesis after the woman had made her choi- 
ce, these attitudes were contrary to the decision 
that both women made, not to undergo amnio- 
centesis. In both cases, the obstetricians attemp- 
ted to dissuade women from this decision. See- 
mingly, in an attempt to dissuade a 40 year old 
woman from declining amniocentesis, the doctor 
presented the probability of Down’s syndrome as 
twice as high as it actually was (101): 
W: You can talk about it until you are blue in 
the face; but you won’t change my mind 
Dr: So, 0 . K  you know the statistics ... the 
chance of you having a baby with Down’s 
syndrome could be as high as 1 in 50. 
The other woman who stated that she did not 
want amniocentesis was asked to consider giving 
birth to a baby with Down’s syndrome, e.g. 
W: I just don’t feel that there is any need (to 
have amniocentesis) and I don’t want to take the 
risk and there is a small risk. 
Dr: The risk of having a miscarriage after an 
amniocentesis is what, something between 1 in 
150 to 200 pregnancies. But your risk of having 
a baby with Down’s syndrome is higher than that 
risk of miscarriage. Now what would you feel if 
you had a baby with Down’s syndrome? 
W Well, I’m a Nursery Nurse. I have worked 
with all types of children so therefore it wouldn’t 
be the end of the world. 
(002): 
4. DISCUSSION 
This small descriptive study illustrates a large 
degree of uniformity in the way that amniocen- 
tesis is routinely offered by obstetricians to 
women at increased risk of having a baby with 
Down’s syndrome, because of maternal age. 
Presentations focused upon the risks of fetal 
abnormality and the risks of pregnancy loss 
following amniocentesis. The probabilities of the 
two events were contrasted on half the occasions 
when they were presented. Implicit in obstetri- 
cians’ presentations was a positive attitude 
towards the use of amniocentesis in routine pre- 
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gnancies in older women. An assumption that all 
women would or should undergo the procedure 
was also evident. 
Three characteristics of test presentation 
deserve comment: first, the terms used to denote 
probability; second, the implicit assumption 
about an appropriate decision, and third, obste- 
tricians’ perceptions of the basis upon which dr:- 
cisions about whether to undergo amniocentesi s 
are made. 
The term risk was used to denote probability, 
and frequently it was used in conjunction with 
words to denote value. Such a blurring of pro- 
bability and value goes against the stated objecti- 
ves of genetic counselling (CotC, 1982), and the 
stated objectives of prenatal testing (Black 
Report, 1979: Royal College of Physicians, 
1989). CotC argues for the importance of the 
terms chosen to denote probabilistic information 
if the purveyor of that information wishes to stay 
neutral. Words like probability, likelihood, 
chances, odds and recurrence rates do not invoke 
a notion of danger, burden or value as implied by 
the term risk. Risks are something to be avoided; 
probabilities are information to be considered in 
making a decision. 
Although obstetricians frequently presented 
probabilistic information, there was a tendency 
for this to be presented in a binary fashion, that 
is, as denoting a high or low risk. This phenome- 
non has been documented in recipients of gene- 
tic counselling, for whom recurrence was percei- 
ved as either something that would or would not 
happen (Lippman-Hand & Fraser, 1979). That 
health professionals too might use this heuristic 
in considering risk requires further study. 
Emphasizing probabilistic information with 
inherent values (e.g. a risk of 1 : 100 for fetal loss 
is low; a risk of 1 : l O O  for Down’s syndrome is 
high) misrepresent how decisions about whether 
to undergo amniocentesis are made. At least two 
factors are relevant. First, it is a woman’s per- 
ception of the likelihood of having an affected 
child that influences her decision, not the actual 
risk (Marteau et al, 1991). Second, concern 
about miscarriage also predicts uptake (Marteau 
et a1 1989). Hence, not all women will view the 
probability of 1 : 100 for fetal loss as low, nor one 
of 1 :I00 for the likelihood of Down’s syndromle 
as high. 
We do not know how satisfied women were 
with this style of presentation. If most women 
had made their decisions about whether to 
undergo amniocentesis before their consulta- 
tions, as suggested by Dixson and colleagues 
(Dixson et a1 1981) they may have found the 
presentation a comforting confirmation of their 
decision. It may, however, be a less comforting 
style for those who had decided not to undergo 
the procedure. For women who enter the consul- 
tation undecided about whether to undergo am- 
niocentesis, they may find the directive style 
eases the burden of decision-making, as sugges- 
ted in a recent study of routine general practice 
consultations (Savage &, Armstrong, 1990). Gi- 
ven the potentially serious consequences of this 
decision, namely diagnosis and termination of an 
affected child, or loss of an unaffected fetus, 
decisions that do not reflect the views of a wo- 
man and her partner may adversely affect their 
ability to cope with these outcomes. 
Little attention was paid to the nature of the 
conditions for which testing was being offered. 
No descriptions were provided for any of the 
conditions mentioned. Nor were women’s under- 
standing of the conditions determined. As part 
of the routine amniocentesis for maternal age, all 
23 pairs of chromosomes are examined. Between 
the ages of 35 and 42, Trisomy 21 (Down’s syn- 
drome) only accounts for about 50% of chromo- 
some anomalies detected at  amniocentesis 
(Harper, 1991). That other chromosome anoma- 
lies will be checked was mentioned in just under 
a third of consultations. The frequency with 
which they occur was never mentioned. These 
results suggest that women are not routinely in- 
formed about the conditions for which their 
fetuses are being tested. This may in part explain 
the confusion and distress for patients and health 
professionals that occur following diagnosis of 
chromosomal anomalies, other than that of 
Down’s syndrome (Rothman, 1986; Morrison & 
Nevin, 1991). It has also been suggested that 
whether parents are told about the possibility of 
sex chromosome anomalies being detected by 
amniocentesis, prior to the procedure, influences 
their decisions about termination of such pre- 
gnancies (Robinson et al, 1989). 
Rarely were women informed about the con- 
ditions for which amniocentesis would not test. 
On a few occasions, the study doctors stated that 
receipt of a normal result on this test meant that 
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the baby would be normal. Routinely available 
prenatal tests however, test for fewer than 50% 
of serious birth abnormalities. Furthermore, no 
mention was ever made of the occasional need to 
repeat the test, following failure to culture any 
cells from the sample obtained. By omitting 
such information, doctors may be encouraging a 
false sense of reassurance for women undergoing 
these tests. 
Occasionally, doctors presented women with 
misinformation. This appeared to reflect both a 
lack of knowledge, and attempts to persuade 
women. The variation in reporting of the miscar- 
riage rate following amniocentesis perhaps 
reflected a lack of knowledge of the results 
from controlled trials. When this information 
was incorrect, it was always an underestimate of 
the rate, suggesting that physicians wish to mi- 
nimize this risk, perhaps in an attempt to per- 
suade women to undergo the procedure. 
Possible factors influencing the presentation 
of amniocentesis include the amount of time 
available in consultations, the knowledge, attitu- 
des and skills of obstetricians, as well as the 
attitudes of pregnant women. 
A feeling of insufficient time to discuss tests 
in more detail during a routine consultation may 
have contributed to the omission of detailed in- 
formation about amniocentesis. Doctors may 
also be presenting this test briefly because they 
lack the knowledge to talk about it at greater 
length. Evidence that staff lack optimal know- 
ledge about screening is provided by a study of 
midwives in Sweden. Forty-five percent of 148 
midwives were found to lack the basic know- 
ledge about AFP (alpha-fetoprotein screening for 
increased risk of open neural tube defects) 
required to inform women about this test, which 
they were routinely presenting as part of antena- 
tal care (Sanden, 1985). 
Several attitudes may have influenced test 
presentation. The brevity of presentation, for 
example, may have arisen from doctors’ atti- 
tudes to patients’ needs for information. It is 
well documented that doctors underestimate 
patients’ need for information and their ability to 
understand such information (Marteau, 1989b). 
It may also reflect doctors’ fears that providing 
too much information will make patients 
anxious. There is little foundation for such a fear. 
The majority of studies report either an anxiety- 
reducing effect of information, or no effect of 
information upon anxiety (Ley, 1988). Only ve- 
ry occasionally has information been found to 
raise anxieties (e.g Visser, 1980). Other studies 
suggest that the impact of information will vary 
according to the individual’s coping style (Miller 
and Mangan, 1983). Studies are needed to deter- 
mine doctors’ beliefs and attitudes about giving 
information to patients. 
A brief presentation which does not empha- 
size patient choice may reflect doctors’ views on 
the purpose of presenting prenatal screening. 
There is disagreement as to the purpose of pre- 
senting prenatal screening tests. While some 
hold with the view that the purpose is to reduce 
the incidence of birth abnormalities (Wald, 1991) 
others have argued that the purpose of presenting 
prenatal screening is to provide prospective pa- 
rents with information about the tests to facilitate 
an informed decision about their use (Royal 
College of Physicians, 1989). 
A further factor influencing how this test is 
presented may be doctors’ skills at presenting 
information. Skills that were evident included 
support for the decisions that women made. The 
data would suggest, however, that this reflected 
support for a decision with which the doctor 
agreed. When positive attitudes were expressed, 
these occurred when women agreed to undergo 
amniocentesis. Negative attitudes were expres- 
sed when women declined the test. Expressing 
positive attitudes towards amniocentesis prior to 
a woman stating her choice demonstrates the di- 
rective nature of some consultations. Obstetri- 
cians do not receive training either in how to 
present information about prenatal tests or in 
communication skills more generally. 
Alternatively, doctors may have the skills to 
present the test in an informative way for the pa- 
tient to decide about uptake, but attempt to en- 
courage test uptake. There are several reasons 
for this, including a belief that medical surveil- 
lance is an important part of obstetric care, that 
fetal abnormality is to be avoided at all costs, or 
that failure of women to undergo tests may result 
in litigation if subsequently a child with an 
abnormality is born. Such concerns will conflict 
with the need to provide patients with informa- 
tion to facilitate an informed decision about test 
uptake. 
It is also possible that while staff presenta- 
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tions may at some time have reflected their atti- 
tudes towards testing, their current presentations 
are now habitual, that is, they are relatively in-  
variant with little need for close conscious atten- 
dance on the part of the performer (Oldfield, 
1959). Such an explanation may reflect the re- 
liance in the UK on a master-apprentice model 
of clinical practice. 
In addition to the influence that staff bring to 
bear upon how prenatal screening tests are dis- 
cussed in the consultation, the knowledge, at1 i- 
tudes and behaviour of women are likely to in- 
fluence how these tests are presented. This was 
not assessed in the current study. The prospect of 
fetal abnormality may be too distressing or 
threatening for both women and obstetricians 1:o 
discuss at length. While 62% of women reported 
after their babys’ births that they had been coil- 
cerned about a fetal abnormality during preg- 
nancy, only 17% of them reported this fear while 
pregnant (Royal College of Midwives, 1966). 
Reluctance to acknowledge this fear overtly 
may therefore be one factor keeping discussion 
of prenatal screening for fetal abnormalities to a 
minimum. 
It is now known whether tape-recording these 
consultations altered the behaviour  of obstetri- 
cians or women. In a recent study in which over 
2000 consultations in primary care were re- 
corded, no evidence was found for associated 
changes in doctors’ behaviour. (Redman et 01, 
1989). 
The results are similar to those of another stu- 
dy of ours describing the presentation by obste- 
tricians and midwives of routine AFP screening 
for spina bifida and Down’s syndrome (Marteau 
et al, 1992). Such results highlight the lack of 
training for obstetricians in presenting complex 
information about prenatal testing in ways coni- 
patible with informed consent. Training will 
need to address attitudes of doctors towards gi- 
ving information and towards women’s roles in 
deciding about prenatal testing, in addition to in- 
creasing their knowledge and skills in providing 
information. Before any training can be carried 
out, however, the most effective and efficient 
ways of achieving this need to be determined 
through controlled, empirically-based studies. 
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ABSTRACT 
The aim of this study is to describe how obstetri- 
cians present amniocentesis to women eligible because 
of their age and hence increased likelihood of having a 
child with Down’s syndrome and other chromosome 
abnormalities. Routine antenatal consultations between 
25 women and 17 doctors were tape recorded. Presen- 
tations focused upon the risks of fetal abnormality, and 
the risks of pregnancy loss following amniocentesis. 
The word risk was used to denote probability and fre- 
quently used in conjunction with words to denote 
value. Although obstetricians frequently presented 
probabilistic information, this tended to be presented 
in a binary fashion, that is, as denoting either high or 
low risk. Equivalent probabilities were described as 
low in connection with fetal loss, and high i n  
connection with Down’s syndrome. The probabilities 
of these two events were contrasted on half of  the 
occasions when they were presented. Implicit in obste- 
tricians’ presentations of amniocentesis was an as- 
sumption that all women would or should undergo the 
procedure. Information concerning the range of  con- 
ditions detected at routine amniocentesis were infre- 
quently mentioned and never described. The results of  
this descriptive study illustrate that information ger- 
mane to decisions of whether to undergo amniocen- 
tesis is frequently presented in such a way as to 
encourage uptake of the test, rather than to foster in- 
formed decision-making. 
RESUMO 
0 objectivo deste estudo C descrever como OS 
obstetras apresentam a amniosintese a mulheres que 
por causa da idade, tCm uma probabilidade elevada de 
ter uma crianqa com sindrome de Down, ou com outra 
anormalidade cromoss6mica. Consultas de rotina prC- 
natal foram gravadas entre 25 mulheres e 17 midicos. 
A apresentaqiio do teste focou-se em relaqiio aos riscos 
de anomalia fetal, e aos riscos de perda do feto a se- 
guir a amniosintese. A palavra ccrisco)) foi usada para 
designar probabilidade e foi frequentemente usada em 
conjunto com palavras para designar valor. Ainda 
que OS obstetras tenham apresentado frequentemente 
informaqlo probabilistica, esta foi apresentada de 
forma binkria, isto 6 ,  designando alto ou baixo risco. 
Da mesma maneira, as probabilidades foram descritas 
como baixas em relaqiio ii perda do feto, e altas em 
relaqlo ao sindrome de Down. As probabilidades des- 
tes dois eventos foram contrastadas em metade das 
ocasiBes em que foram apresentadas. Na apresentaqiio 
da amniosintese feita pelos obstetras, estava implicita 
a suposiqiio de que todas as mulheres deviam ser sub- 
metidas ao teste. InformaqBo relativa ao leque de pos- 
siveis anomalias detectiiveis pela amniosintese, niio foi 
mencionada frequentemente, e as anomalias nunca fo- 
ram descritas. OS resultados deste estudo descritivo 
ilustram que a informaqlo relevante para a tomada de 
decisiio relativa a realizaqlo da amniosintese, C fre- 
quentemente apresentada de forma a favorecer a rea- 
lizaqiio do teste, em vez de fornecer a inforrnaqBo ne- 
cessiria a tomada de decisiio sobre a realizaqiio do 
mesmo. 
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